Safety Pharmacology

Finding a partner with the expertise and guidance to help guide your project through a dynamic regulatory landscape and provide meaningful data to drive decision making is essential for meeting milestones on-time and accelerating to commercialization.

ICH S7A and S7B guidelines for the conduct of safety pharmacology evaluations recommend a core battery of studies on three vital systems – the central nervous system, cardiovascular system and respiratory system – to assess the acute and potentially life-threatening risks of novel pharmaceuticals for human use. Explore how Charles River’s core battery and comprehensive selection of supplemental tests can provide customized safety pharmacology studies best suited for your project’s needs.